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Summary
For entry and infection viruses have developed
numerous strategies to subjugate indispensable
cellular factors and functions. Host cell lipids and
cellular lipid synthesis machinery are no excep-
tion. Not only do viruses exploit existing lipid sig-
nalling and modifications for virus entry and
trafficking, they also reprogram lipid synthesis,
metabolism, and compartmentalization for assem-
bly and egress. Here we review these various
concepts and highlight recent progress in under-
standing viral interactions with host cell lipids
during entry and assembly.
Introduction
Lipids are a highly diverse group of naturally occurring
hydrophobic biomolecules indispensible for cellular life.
The biological functions of lipids range from membrane
formation to energy storage and signalling (Voelker, 1991;
van Meer et al., 2008; Vanhaesebroeck et al., 2012). As
the main building block of biological membranes in
eukaryotic cells, lipids serve for compartmentalization of
organelles and their diverse functions. The plasma mem-
brane, for instance, serves to selectively separate the
intra- and extracellular environments and acts as the first
barrier against invading pathogens (van Meer et al.,
2008).
Investigation of the interaction between viruses and
their host cells provides invaluable insights into the
molecular mechanisms of viral pathogenesis and on host
cell biology. How viruses enter host cells and systemati-
cally reprogram the cellular environment is one of the
most compelling subjects in host–pathogen interaction.
Recent work on multiple aspects of the role played by
cellular lipids during the infection process has revealed
their importance throughout the entire lifecycle of viruses
(Heaton and Randall, 2011; Lorizate and Krausslich,
2011). These interactions range from virus binding to the
host cell plasma membrane, to the release of new infec-
tious progeny into the extracellular space. The emerging
picture suggests that viruses take advantage of cell lipids
by two means: subjugation and reprogramming. During
early stages of infection, viruses subvert pre-existing cel-
lular lipids and lipid signalling mechanisms for entry and
trafficking. Once infection is initiated and viral genes
expressed, extensive reprogramming of lipid synthesis
and remodelling of lipid distribution serves to promote viral
replication, assembly, and egress. This review focuses
on how viruses exploit cellular lipids to promote entry
and reorganize cell lipid composition, localization, and
metabolism for the generation of progeny virions capable
of propagating infection (illustrated in Fig. 1).
Cellular lipids and virus entry
The first encounter between a virus and a target cell
occurs at the plasma membrane. It is here that viruses
first engage binding and entry receptors to initiate the
infection process. In addition to acting as the main barrier
between the cells and their external environment, the
plasma membrane controls and co-ordinates the internali-
zation of particles and fluids through different endocytic
uptake mechanisms (reviewed in Doherty and McMahon,
2009); not surprisingly, viruses have learned to subjugate
most of these for their own entry (Mercer et al., 2010b).
In animal cells, phospholipids account for more than
half of the lipids in cellular membranes. The plasma mem-
brane also contains glycolipids and cholesterol, the latter
important for regulating membrane fluidity. While lipids
mostly diffuse freely in the plasma membrane, choles-
terol, glycosphingolipids (glycolipids and sphingomyelin),
glycophosphatidylinositol (GPI)-anchored proteins, and
transmembrane proteins can cluster into discrete
domains, called lipid rafts (Simons and Ikonen, 1997;
Levental et al., 2010; Simons and Sampaio, 2011). Lipid
rafts play an important role in signalling and membrane
organization, but also serve as an important platform used
by both enveloped and non-enveloped viruses to enter
cells (Marsh and Helenius, 2006; Mercer et al., 2010b;
Ewers and Helenius, 2011).
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Adhesion and attachment
For most viruses, enveloped and non-enveloped, entry is
preceded and enhanced by weak ionic interactions
between the virion and cell surface glycosaminoglycans
(e.g. heparan and chondroitin sulfate) or glycos-
phingolipids (Lorizate and Krausslich, 2011). These
interactions promote adhesion of the virion to the cell
membrane, allowing the virus to surf along the cell surface
until recognition of specific binding or internalization
receptors occurs. Trafficking on the cell surface or through
the endosome network serves to bring the virus to its
preferred site of uncoating, while providing the cues
needed to activate the virus fusion machinery (Marsh and
Helenius, 2006). While normally non-specific in nature,
different glycosphingolipids on the viral surface have been
reported to confer cell specificity: the sialyllactose moiety
on human immunodeficiency virus (HIV) membrane
gangliosides, for instance, has been suggested to
promote uptake of HIV into mature dendritic cells (mDCs)
(Izquierdo-Useros et al., 2012). Gangliosides are acidic
glycosphingolipids carrying one or more terminal sialic
acid; by using liposomes mimicking the composition and
size of HIV, the authors demonstrated that gangliosides
GM1, GM2 and GM3 are the key molecules that mediate
liposome uptake in mDCs, with the sialyllactose moiety on
gangliosides acting as a molecular recognition pattern.
Recognition and uptake of sialyllactose moieties on
gangliosides is likely to be a common mechanism of par-
ticle internalization by DCs, leading to antigen processing
and presentation; however, in the case of HIV, the
antigen-processing function of mDCs is subverted, as
the virus rather uses these for virus transmission
(Izquierdo-Useros et al., 2012).
Lipid-mediated signalling for entry
While most viruses use surface proteins or sugars to
promote entry, lipids can also function as virus entry
Fig. 1. Virus-mediated subjugation and
modulation of host lipids during infection. The
lifecycle of most viruses proceeds through
a series of basic steps: binding and
internalization, fusion, uncoating of the viral
genome, its replication, assembly of new
particles, and budding or release of the newly
made viruses. A multitude of viruses have
learned to take advantage of host cell lipids
during each of these stages. For binding and
entry viruses hijack lipid based receptors and
utilize existing lipid-based signalling. They rely
on host phosphatidylinositol phosphate
signalling for endosomal trafficking and
differential endosomal lipid composition to
assure fusion occurs at the appropriate time
and place. Once viral gene expression
ensues, viruses express factors to subjugate
intracellular membrane compartments to build
replication complexes, assemble viral
factories, and alter lipid metabolism. Pictured
are the stages of virus infection in which
interplay between viruses and host lipids
occur. The various stages in the lifecycle of a
virus in which cellular lipids can be altered or
subjugated are pictured with example viruses
listed in parentheses (see text for details).
SV40 (simian virus 40); VSV (vesicular
stomatitis virus); IAV (influenza A virus);
VACV (vaccinia virus); HSV-1
(herpes simplex virus 1); BMP
[bis(monoacylglycero)phosphate]; DENV
(dengue virus); WNV (West Nile virus);
HCV (hepatitis C virus); HCMV (human
cytomegalovirus); HIV (human
immunodeficiency virus); EE (early
endosome); LE (late endosome); GM1 (GM1
ganglioside); PS (phosphatidylserine); PI3K
(phosphoinositde-3 kinase).
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receptors. Low-density lipoprotein receptors, negatively
charged phospholipids and gangliosides have all been
shown to assist entry of different viruses (Agnello et al.,
1999; Tsai et al., 2003; Campanero-Rhodes et al., 2007;
Roth and Whittaker, 2011; Izquierdo-Useros et al., 2012;
Meisen et al., 2012).
Gangliosides, in particular, have been shown to be
required for entry of the non-enveloped polyomavirus
simian virus 40 (SV40). Upon specific binding to
ganglioside GM1, SV40 reduces GM1’s diffusion rate.
This stabilized SV40-GM1 complex then recruits choles-
terol to generate a lipid raft. The interaction induces
actin-dependent immobilization of the virus-ganglioside
complex, followed by virus-induced invagination of the
plasma membrane. An elegant study by Ewers et al. has
demonstrated that association of SV40, or the isolated
pentameric receptor VP1, with GM1 is sufficient to induce
membrane curvatures that lead to the formation of deep
invaginations in the plasma membrane of the cell (Ewers
et al., 2010). Other polyomaviruses, as well as Shiga and
cholera toxin, can also induce plasma membrane curva-
ture and promote their endocytic uptake (Romer et al.,
2007; Wolf et al., 2008).
Low-density lipoprotein receptors, also known as cho-
lesterol receptors, are used by several members of the
Flaviviridae family, including hepatitis C virus (HCV)
(Agnello et al., 1999). The interaction is likely to occur
through lipoproteins associated with the virion, such as
cholesteryl esters and apolipoproteins (ApoB and ApoE)
acquired during the assembly and budding of virus
(Targett-Adams et al., 2010; Alvisi et al., 2011), as dis-
cussed below.
Recent reports have also indicated that the trans-
membrane, cholesterol-sensing receptors Niemann-Pick
C1 (NPC1) and Niemann-Pick C1-like 1 (NPC1L1) are
important entry factors for filovirus (Carette et al., 2011)
and HCV (Sainz et al., 2012) respectively. For filoviruses,
silencing of NPC1 prevents fusion from lysosomal com-
partments. In contrast to NPC1L1-mediated HCV entry
(Sainz et al., 2012), this was independent of the choles-
terol binding activity of NPC1 (Carette et al., 2011).
Whether the cholesterol transport function of NPC1
receptors is required for infectivity is unclear, but these
results suggest that the NPC1 receptors can facilitate
virus entry in a cholesterol-dependent and -independent
fashion.
Finally, negatively charged phospholipids have been
implicated as virus receptors for vesicular stomatitis virus
(VSV). Entry of VSV has been suggested to require the
interaction between the viral glycoprotein G and the nega-
tively charged phospholipid phosphatidylserine (PS) on
the cell surface (Carneiro et al., 2006). However, whether
these molecules are the actual receptor for VSV entry has
been challenged and is not clear (Coil and Miller, 2004).
Lipid signalling during virus endosomal trafficking
Attachment to cellular receptors commonly activates sig-
nalling pathways that induce endocytosis of the virus.
Regardless of the mechanism used for uptake, trafficking
within the endosomal network is a highly co-ordinated
process. After formation, endosomes go through matura-
tion, a process that involves defined changes in cellular
location, pH, protein and lipid composition (Fig. 1 for
details).
The importance of lipids in co-ordinating these various
events has come to light in the past decade.
Phosphatidylinositol (PI) is the least abundant phospho-
lipid in the cell membrane, but it is also one of the most
versatile signalling molecules in cells and plays a central
role in endosome trafficking and maturation. Differential
phosphorylation of PI, regulated by specific PI kinases
and phosphatases, results in the formation of different PI
phosphate (PIP) species (reviewed in Vicinanza et al.,
2008; Vanhaesebroeck et al., 2012). The constrained
localization of these enzymes leads to differential concen-
trations of the PIPs within various cellular compartments;
in turn, this compartmentalization influences PIPs signal-
ling and protein recruitment activities.
Many viruses have evolved to exploit PI-mediated
signalling at different stages of infection, and in particu-
lar, to co-ordinate virus entry and trigger downstream
reprogramming of the host cell. The Class I PI3-kinase
(PI3K) signalling pathway is one of the most important
PI-mediated signalling cascades activated during virus
entry. Activation of PI3K and subsequent generation of
PIP3 serves as docking platform for proteins carrying
lipid-binding domains, including Akt, the main effector of
PI3K signalling (Das et al., 2010). While PI3K is involved
in all forms of endocytosis (Doherty and McMahon, 2009;
Mercer et al., 2010b; Antonescu et al., 2011), it is best
characterized for its role in macropinocytosis, where
PI3K serves to co-ordinate signalling and cytoskeletal
modulation during protrusion, extension, and closure
phases of macropinosome formation (Lindmo and
Stenmark, 2006; Bohdanowicz and Grinstein, 2013).
Activation of PI3K upon virus binding has been observed
for a number of viruses using this entry mechanism,
including influenza (Fujioka et al., 2011; Marjuki et al.,
2011), Herpes simplex virus type 1 (HSV-1) (Zheng et al.,
2014), HCV (Berger et al., 2009), Zaire Ebola Virus
(ZEBOV) (Saeed et al., 2008), and vaccinia virus (VACV)
(Mercer and Helenius, 2008; Mercer et al., 2010b;
Izmailyan et al., 2012).
In addition to its crucial role in virus entry and trafficking,
many viruses activate PI3K signalling for modulation
of post-internalization events such as virus replication
and assembly (highlighted in Diehl and Schaal, 2013).
VACV, for example, requires activation of PI3K early for
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macropinocytic internalization (Mercer and Helenius,
2008; Mercer et al., 2010a; Izmailyan et al., 2012), and
PI3K- Akt late to attenuate apoptosis of infected cells
(Soares et al., 2009). In line with this, VACV is acutely
sensitive to pharmacological inhibition of PI3K or Akt
activity, which reduces viral yield up to 90% (Mercer and
Helenius, 2008; Soares et al., 2009; Mercer et al., 2010a).
The collective evidence indicates that activation of the
PI3K signalling pathway is a widespread strategy used by
multiple viruses to different ends (Diehl and Schaal,
2013).
Lipids, membrane curvature and virus fusion
The molecular shape of membrane lipids within
endosomes can strongly influence virus fusion activities.
For fusion from endosomes, after internalization and acti-
vation of viral fusion machinery, the viral fusion peptide
inserts into the target endosome membrane. Fusion of
viral and cell membranes then proceeds through a tran-
sient hemifusion intermediate where the outer leaflet of
the viral membrane mixes with the inner leaflet of the
endosome membrane. Subsequently, the inner viral and
outer endosomal membrane leaflets merge and the
hemifusion stalk opens, forming the fusion pore and thus
completing the fusion process (Lorizate and Krausslich,
2011). Interestingly, lipid composition influences from
which endosomal compartment a virus will fuse. For
instance, dengue virus (DENV) exploits the late
endosome specific anionic lipid bis(monoacylglycero)
phosphate (BMP) to promote fusion from late endo-
somes. The lipid-dependence of DENV fusion machinery
assures that DENV does not fuse prematurely (Zaitseva
et al., 2010). Endosomal lipid content has also been
shown to be important for West Nile and alphavirus
fusion, requiring either cholesterol or both cholesterol
and sphingolipids respectively (Kielian et al., 2010;
Moesker et al., 2010). Given the importance of lipids
during this stage of virus entry, it comes to no surprise
that host cells have developed strategies to counteract
the interaction between viral and cellular membranes.
Recent description of interferon-inducible transmem-
brane (IFITM) proteins and 25-hydroxycholesterol as
viral restrictions factors serve as good examples (see
Appendix 1).
Cellular lipids during viral infection
Subjugation of cellular lipids by viruses is not only used to
promote entry and intracellular trafficking. In fact viruses
also use lipids to modify their own proteins as well as
cellular factors to promote viral replication complex forma-
tion, production of new viral particles, viral egress and
spread of infection.
Lipids and viral replication complex formation
Viruses that replicate in the cytosol tend to reorganize
cellular membranes to create sites of active replication.
These sites, called viral factories or replication complexes
(RC) provide a scaffold for the viral replication machinery,
serve to concentrate the viral and cellular factors needed
for assembly of new virions, and provide a protective
environment for avoidance of cellular innate immune
responses. Examples include the large dsDNA poxviruses
which transiently recruit endoplasmic reticulum (ER)-
derived cisternae around viral RCs (Condit et al., 2006;
Krijnse Locker et al., 2013), and positive stranded
RNA viruses which reorganize ER, Golgi, endosomal,
lysosomal or mitochondrial membranes to form special-
ized membrane-bound RCs (Miyanari et al., 2007; Miller
and Krijnse-Locker, 2008; Welsch et al., 2009; den Boon
et al., 2010; Heaton et al., 2010).
A number of studies are now shedding light on virus-
mediated modification of lipid profiles in order to shape
the cellular membrane environment to promote infection.
Membrane remodelling induced by DENV, for instance,
is directly linked to a shift in the lipid repertoire during
infection (Perera et al., 2012). High-resolution mass-
spectrometry studies in mosquito cells indicates that
together with lipids involved in controlling membrane
fusion, fission, trafficking and cytoskeletal function, those
able to change membrane curvature or permeability are
enriched in DENV infected cells (Heaton et al., 2010;
Perera et al., 2012).
Recent work has revealed that several of these viruses
co-opt cellular cofactors to facilitate virus-mediated mem-
brane remodelling. The NS5A protein of Hepatitis C virus
(HCV), for instance, recruits PI4K-IIIα to virus replication
sites to increase local levels of PI(4)P (Alvisi et al., 2011),
while the picornavirus protein 3A recruits PI4K-IIIβ to the
same end (Greninger et al., 2012). It has been proposed
that high levels of PI(4)P directly contribute to RC forma-
tion by influencing membrane bending or by regulation of
intracellular processes including vesicle fusion, budding
and sorting (Berger et al., 2009; Alvisi et al., 2011).
In addition to subverting lipids for its replication, HCV
subjugates existing lipid droplets (LDs) for assembly of
infectious viral particles (Miyanari et al., 2007). Under
normal conditions, lipid droplets serve as storage orga-
nelles for neutral lipids. During HCV infection viral core
protein associates and accumulates on LDs. These
virus-modified structures become surrounded by HCV
RC-containing membranes and associated viral RNA and
non-structural proteins. Although not fully understood,
co-ordinated events occur between HCV RCs containing
replicated genomes, and the viral core containing LDs
for complete genome packaging and virus assembly
(Miyanari et al., 2007).
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Virus subversion of lipid metabolism
That viruses impact cell metabolism has been known
for many years. However, advances in the field of
metabolomics have only recently allowed us to fully
appreciate the extent to which viruses reprogram host cell
metabolism. Recent studies on several different viruses
indicate that metabolic pathways and enzymes tend to be
manipulated in a virus specific fashion. This is likely
dependent upon the metabolic precursors the individual
viruses find most advantageous for their replication. Not
too surprisingly, all of these studies have identified impor-
tant alterations in lipid synthesis upon viral infection. By
altering the activity of the tricarboxylic acid (TCA) cycle or
by manipulating the carbon source used by the cells to
generate energy and macromolecules, several viruses
take control of central energy metabolism to promote syn-
thesis of cholesterol and fatty acids. This phenomenon
has been described for two large enveloped viruses:
HCMV (Vastag et al., 2011; Yu et al., 2011) and VACV
(Greseth and Traktman, 2014). This is likely to be required
to assure sufficient viral lipid membrane for building new
viral progeny, and for remodelling of viral and cellular
membranes to enhance viral replication, egress and entry
into neighbouring cells.
Large enveloped viruses are not the only viruses that
manipulate cellular lipid metabolism. Microarray analysis
of HCV infected cells show significant changes in
the expression of genes involved in lipid metabolism
(Woodhouse et al., 2010). Recent transcriptomic and
proteomic analyses indicate that the expression of host
genes involved in lipid biosynthesis, degradation, and
transport is profoundly altered by HCV; in particular cho-
lesterol biosynthesis genes were found to be upregulated
(Woodhouse et al., 2010). Parallel lipidomics analysis
also showed changes in selected lipid species, particu-
larly phospholipids and sphingomyelin (Diamond et al.,
2010). This suggests that HCV reprogramming of host
lipid metabolism attempts to maintain host homeostasis in
spite of the elevated demand of metabolic precursors by
the virus.
Modulation of cell lipids for virus assembly
and infectivity
To complete the cycle of infection, newly assembled
virions must have the ability to infect naive cells. Thus the
importance of lipids during this last stage of the viral life
cycle is twofold: not only are they required for assembly
and release of new viral particles, in some cases the lipid
content of the viral particles dictates virus infectivity.
Most enveloped viruses acquire their envelope by
budding. This can occur either at the plasma membrane
or internal membranes. The majority of retroviruses,
paramyxoviruses, and orthomyxoviruses bud from the
plasma membrane; flaviviruses bud from the ER mem-
brane, and HSV gains its envelope from trans Golgi
network (TGN) or endosomes (Lorizate and Krausslich,
2011). As lipids play a central role in this process, it is not
surprising that viruses promote lipid synthesis and reor-
ganization of cellular membrane lipid composition for
virus assembly and exit. HIV, which buds from plasma
membrane lipid rafts provides an interesting example.
HIV actively modulates lipid rafts by increasing the
synthesis and trafficking of cholesterol to these sites
(Aloia et al., 1993). Analysis of the viral membrane has
revealed that it is enriched in sphingolipids and choles-
terol at the expense of phosphatidylcholines, confirming
its raft origin (Aloia et al., 1993). Also, the major HIV
structural protein responsible for assembly of the
budding structure, Gag, localizes in lipid rafts through
interactions with the lipid signalling molecule PIP2 to
ensures the correct localization of Gag for viral assembly
and budding (Aloia et al., 1993; Barrero-Villar et al.,
2008; Lorizate et al., 2013).
In addition to modifying the lipid content of existing
membranes to co-ordinate virus budding, viruses can
promote the active synthesis of lipids to provide mem-
branes for the viral envelope. The increased biosynthesis
of fatty acids, observed during HCMV and VACV infec-
tions is thought to increase the available membranes for
viral membrane wrapping and assembly respectively.
Interestingly in these cases the viral lipid content is altered
with respect to host cell membranes. HCMV has been
shown to contain more phosphatidylethanolamines and
less phosphatidylserine than the host cell membrane. This
lipid content, which resembles that of synaptic vesicles, is
thought to facilitate HCMV budding and release (Liu et al.,
2011).
In contrast, the VACV membrane is enriched for
phosphatidylserine (PS) (Ichihashi and Oie, 1983)
facilitating the next round infection by PS-dependent
macropinocytic entry (Mercer and Helenius, 2008). With
the exposure of PS, VACV mature viruses (MVs) resem-
ble apoptotic bodies. As apoptotic clearance can occur by
macropinocytosis (Hoffmann et al., 2001) we postulated
that VACV employs apoptotic mimicry (Mercer and
Helenius, 2010). Despite our demonstration that the virus
can directly bind to the PS receptor Axl (Frei et al., 2012),
the PS receptors (TAMs, TIMs, stablin-2, MFGE-8) and
bridging molecules (serum protein S and Gas6) (Scott
et al., 2001; Hanayama et al., 2002; Hafizi and Dahlback,
2006; Miyanishi et al., 2007; Park et al., 2008) used by
VACV remain elusive. It will be of interest to determine if
VACV PS receptor(s) bind phosphatidylglycerol or the
D-stereoisomer of PS, two lipids absent from the MV
membrane that can functionally substitute for the naturally
occurring PS (Laliberte and Moss, 2009).
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Since its inception, viral apoptotic mimicry has proven
to be a widespread lipid-mediated entry mechanism
used by several enveloped viruses including: pichinde,
cytomegalo, lassa fever, lenti, dengue, ebola and Marburg
viruses (Callahan et al., 2003; Shimojima et al., 2006;
Soares et al., 2008; Hunt et al., 2011; Kondratowicz et al.,
2011; Mercer, 2011; Meertens et al., 2012; Jemielity et al.,
2013; Moller-Tank et al., 2013; Morizono and Chen,
2014). For several of these viruses the PS-receptors and
bridging molecules required for entry have now been
defined (Shimojima et al., 2006; Hunt et al., 2011;
Kondratowicz et al., 2011; Mercer, 2011; Meertens et al.,
2012; Jemielity et al., 2013; Moller-Tank et al., 2013).
That antibodies directed against PS can neutralize
lethal pichinde and cytomegalo virus infections (Soares
et al., 2008), and virus engagement of PS receptors
can dampen innate immune responses to infection
(Bhattacharyya et al., 2013) suggests that the therapeutic
potential of PS targeting deserves further investigation.
Future perspectives
The fundamental role of lipids in virus biology and infec-
tion is becoming increasingly clear. New technologies,
such metabolomics, and advances in mass spectrometry-
based lipidomics are allowing for systematic characteriza-
tion of the alterations in host lipid metabolism, as well as
cellular and viral lipid profiles induced by viral infection.
As highlighted in this review, lipids serve to orchestrate
different stages of viral replication, ranging from entry to
spread. Viruses take control of lipid-mediated signalling to
co-ordinate viral entry and intracellular trafficking. Later
during infection, they actively modify intracellular mem-
brane for replication, re-direct lipid metabolism to produce
sufficient membrane for the assembly of new particles,
and modify cell membrane lipid content to ensure infec-
tivity of those virions.
Systematic characterization of how viruses take control
of and alter lipid metabolism is now needed to unravel
the common strategies used by these different viruses.
Such studies may serve for the identification of infection
biomarkers; and together with the development of thera-
peutics targeting subsets of lipid synthesis enzymes it
may be possible to identify novel broad-spectrum thera-
peutic agents that target virus modified lipid metabolism.
Overall, a deeper understanding of how viruses manipu-
late the host cells lipid program will serve to further our
understanding of the cellular mechanisms that govern
lipid modification, compartmentalization and metabolism.
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Appendix 1
IFITMs and 25-HC as viral restriction factors
About 20 years after their identification as interferon stimulated
genes (ISGs) (Lewin et al., 1991), interferon-inducible
transmembrane (IFITM) proteins were characterized as viral
restriction factors (Brass et al., 2009). Interestingly, while most
known restriction factors act after viral entry, IFITM proteins were
shown to restrict viral fusion. Since the initial study describing the
role of IFITM proteins as influenza A virus (IAV) and flavivirus
restriction factors (Brass et al., 2009), several other studies have
followed showing the importance of these proteins in inhibiting
entry of many other viruses including filoviruses (Huang et al.,
2011), rhabdoviruses (Weidner et al., 2010; Smith et al., 2013),
bunyaviruses (Mudhasani et al., 2013), and the non-enveloped
reoviruses (Anafu et al., 2013).
Each of the three IFITM proteins has different cellular
localizations which determine the range of viruses they restrict.
IFITM1 is located primarily at the plasma membrane; IFITM2 and
3 localize in intracellular compartments, with IFITM3 colocalizing
with endosomal markers (reviewed in Smith et al., 2014). IFITM3
has been shown to block fusion of viral and cell membranes –
plasma or endosomal – via reduction of membrane fluidity (Li
et al., 2013). While the exact mechanism of action is not clear,
one study suggests that IFITM3 reduces membrane fluidity and
increase positive curvature in the outer leaflet of the host mem-
brane: by interacting with vesicles membrane protein associated
protein A (VAPA), IFITM3 would disrupt the association between
VAPA and an oxysterol binding protein that regulates the content
of cholesterol in endosomal membrane, therefore restricting viral
fusion (Amini-Bavil-Olyaee et al., 2013). More recent reports
have however contradicted this hypothesis, demonstrating that
an increase in the concentrations of cholesterol in cellular mem-
branes is not itself sufficient to inhibit fusion, and suggests
instead that, directly or indirectly, IFITM3 might interfere with pore
formation in the cytoplasmic leaflet of the hemifusion intermedi-
ate or, alternatively, that they might re-direct viral fusion to a
non-productive pathway (Desai et al., 2014). Inhibition of non-
enveloped viruses as reovirus, and lack of inhibition of enveloped
viruses like arenaviruses (Brass et al., 2009) and some major
DNA viruses like papilloma virus, human cytomegalovirus and
adenovirus (Warren et al., 2014) also suggest that much more
still needs to be discovered, and also introduces the possibility
that some viruses might have evolved to specifically evade this
antiviral mechanism.
Recent findings also indicate that repression of the sterol
biosynthetic pathway is an important component of the
interferon-inducible antiviral response (Blanc et al., 2011). An
overexpression screen aimed at identifying IFN-induced antiviral
effectors has clarified a role for 25-hydroxycholesterol (25HC) in
inhibiting infection of several enveloped viruses (Liu et al., 2012).
25HC was reported to inhibit virus-cell fusion through direct
alteration of cellular membrane composition (Liu et al., 2013),
although it is also possible that viral infection is modulated at
multiple post-entry events (Schoggins and Randall, 2013).
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